Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma

This study set out to evaluate, in patients with metastatic colorectal carcinoma, the efficacy and toxicity of S-1, which contains tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP) and potassium oxonate, based on a biochemical modulation of 5-fluorouracil (5-FU) targeted at inhibition of dihydropyrimid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohtsu, A, Baba, H, Sakata, Y, Mitachi, Y, Horikoshi, N, Sugimachi, K, Taguchi, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363492/
https://www.ncbi.nlm.nih.gov/pubmed/10901361
http://dx.doi.org/10.1054/bjoc.2000.1236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363492/
https://www.ncbi.nlm.nih.gov/pubmed/10901361
http://dx.doi.org/10.1054/bjoc.2000.1236

Ejemplares similares